what happens when you microdose glp 1 Microdosing GLP-1s: Safety, Dosage, Side Effects, and Results Microdosing of GLP-1's / Wellness
Description
The analysis spanned data from January 1, 2015, to December 31, 2023
Sources for Figure 218
Both its dual-agonist injectable poterepatide and its oral small molecule conveglipron are in Phase III, demonstrating significant late-stage momentum
To achieve sustained therapeutic benefits, continued treatment with these agents may be necessary
Unlike pharmaceutical GLP-1 drugs, this product focuses onfeeding beneficial gut bacteria, which indirectly supports the bodys natural hormone production
